Is Ainos, Inc. (AIMDW) a Buy, Sell, or Hold?
NASDAQ : AIMDW
Ainos, Inc.
$0.1139 USD
$0.06 (107.09%)
- Volume
- 727
- Average Volume
- 4.77K
- Market Capitalization
- $5.93M
- P/E Ratio
- -0.56
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $0.17
- Year Low
- $0.08
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.13
Company Overview
NASDAQ
Chun-Hsien Tsai
Biotechnology
Healthcare
AIMDW
41
US
USD
Liquidity Metrics
3.35
0.13
0.12
0.09
0.00
Sales & Valuation
$124.16K
770.98
3.18
-2.33
-0.61
Profitability
-$3.46
-$14.77M
-106283.32%
-106277.43%
-217.50%
-73.89%
P/E Metrics
-0.56
0.00
0.00
Analyst Price Target & Rating
2/5
0 Analysts
%
Financial Health Scores
-8.35
3/9
-$14.09M
$19.56M
$16.28M
-$13.74M
Key Metrics (TTM)
$15.96M
1173.62
-1.78
0.13
-217.50%
-96.36%
-139.34%
-70.40%
24 days
Company Executives
| Name | Title |
|---|---|
| Chun-Hsien Tsai | Chief Executive Officer, President & Chairman of the Board |
| Chih-Heng Lu | Director of Corporate Developoment |
| Hsin-Liang Lee | Chief Financial Officer |
Poll Results
No votes yet today — be the first to share your view!
About Ainos, Inc. (NASDAQ:AIMDW) Stock
Ainos, Inc. operates as a healthcare enterprise dedicated to advancing medical technologies. Its core focus involves developing both point-of-care diagnostic solutions and innovative, safe therapeutic options for various health conditions. The company's offerings include a COVID-19 antigen rapid test kit. This is complemented by the Ainos' cloud-based test management App, a holistic platform comprising the rapid test kit, a personal mobile application, and an enterprise-level app. Ainos also provides a COVID-19 nucleic acid test. Further technologies under development or offered include point-of-care testing for volatile organic compounds and Very Low-Dose Oral Interferon Alpha, an oral formulation of IFN-a with broad therapeutic potential. The firm is additionally developing a Synthetic R ... NA (SRNA) technology platform, with specific work being conducted in Taiwan. Beyond these, Ainos' product line extends to women's health, pneumonia, the Ainos Pen, AI Nose, and a variety of other products. Originally incorporated in 1984, the company was formerly known as Amarillo Biosciences, Inc. and rebranded to Ainos, Inc. in May 2021. Its main operations are based in San Diego, California.
Frequently Asked Questions
-
What is the current Ainos, Inc. (AIMDW) stock price?
-
Ainos, Inc.(NASDAQ:AIMDW) stock price is $0.1139 in the last trading session. During the trading session, AIMDW stock reached the peak price of $0.17 while $0.0758 was the lowest point it dropped to. The percentage change in AIMDW stock occurred in the recent session was 107.09% while the dollar amount for the price change in AIMDW stock was $0.06.
-
AIMDW's industry and sector of operation?
-
The NASDAQ listed AIMDW is part of Biotechnology industry that operates in the broader Healthcare sector.
-
Who are the executives of AIMDW?
-
Chun-Hsien Tsai | Chief Executive Officer, President & Chairman of the Board
Chih-Heng Lu | Director of Corporate Developoment
Hsin-Liang Lee | Chief Financial Officer
|
| -
How many employees does AIMDW have?
-
Number of AIMDW employees currently stands at 41. AIMDW operates from 3050 Post Oak Boulevard, Houston, TX 77056, US.
-
Link for AIMDW official website?
-
Official Website of AIMDW is: https://www.ainos.com
-
How do I contact AIMDW?
-
AIMDW could be contacted at phone #858 869 2986 and can also be accessed through its website. AIMDW operates from 3050 Post Oak Boulevard, Houston, TX 77056, US.
-
How many shares of AIMDW are traded daily?
-
The average number of AIMDW shares traded daily for last 3 months was 4.77K.
-
What is the market cap of AIMDW currently?
-
The market value of AIMDW currently stands at $5.93M with its latest stock price at $0.1139